Lactose intolerance and its association with the exogamy degree among the population of eastern Ukraine

  • O. M. Fedota
  • V. O. Babalian
  • V. V. Borozenets
  • S. M. Mazniakov
  • N. G. Puzik


Aim. The aim of our study was to evaluate the relationship between exogamy degree and lactose assimialation among the population of Eastern Ukraine in the Kharkiv region. Methods. The analysis included information on consumption and assimilation of milk and dairy products by 733 people aged from 14 to 79 years were. Statistical analysis included Shapiro-Wilk test, Pearson fitting (χ2) criterion and Spearman’s correlation analysis. Results. The lactose tolerance (LT) phenotype was found in 69.5%, whereas lactose intolerance (LI) – in 8.8% (from 3.5% to 24.1% in different age groups). In the age group 30-39 years: LI frequency was 24.1% being 2.5-6 times higher than in other groups. The exogamy degree of parents (EDP) showed in the group aged from 30 to 39 years the first EDP was 15.4%, being 1.4-2.5 times less (p = 0,05) than in other groups. Among people with bone marrow disorders the proportion of people with the first and second EDP was 60.9%, being 2.1 to 6.0 times higher than in other groups. Reduced EDP or increased inbreeding level causes the similarity of the chromosomes and affects the density of contact points between them during meiosis, level of recombination can be increased and associated with multifactorial traits. Conclusions. The results can be explained by the effect of the inbreeding level reduction in the presence of a high level of exogamy of parents, which causes high genetic diversity.

Keywords: lactose intolerance, lactose tolerance, exogamy degree of parents, single nucleotide polymorphisms 13910C-T and 22018G-A, gene МСМ6.


Feldman MW, Cavalli-Sforza LL. On the theory of evolution under genetic and cultural transmission with application to the lactose absorption problem. In: Feldman MW (ed) Mathematical evolutionary theory. Princeton University Press, Princeton, 1989. P. 145–173.

Mattar R., Ferraz de Campos Mazo D., Carrilho F.J. Lactose intolerance: diagnosis, genetic, and clinical factors. Clin Exp Gas-troenterol. 2012. Vol. 5. P. 113–121. doi: [10.2147/CEG.S32368].

Friedrich D.C., de Andrade F.M., Fiegenbaum M., de Almeida S., Mattevi V.S., Callegari-Jacques S.M., Hutz M.H. The lac-tase persistence genotype is a protective factor for the metabolic syndrome. Genet Mol Biol. 2014. Vol. 37 (4). P. 611–615. doi: 10.1590/S1415-47572014005000012.

Krûmiòa A., Pliss L., Zariòa G., Puzuka A., Zariòa A., Lâce B., Elferts D., Khrunin A., Limborska S., Kloviòð J., Gailîte (Pie-kuse) L. Population genetics of latvians in the contextofadmixture between north-eastern European ethnic groups. Proceedings of the latvian academy of sciences. 2018. Vol. 72 (3). P. 131–151. doi: 10.2478/prolas-2018-0025.

Burger J., Kirchner M., Bramanti B., HaakW., Thomas M.G. Absence of the lactase-persistence-associated allele in early Neo-lithic Europeans. Proc Natl Acad Sci USA. 2007. Vol. 104 (10). P. 3736–3741. doi: [10.1073/pnas.0607187104].

Sen O., Ruban S., Getya A., Nesterov Y., Kuipers A., Rozstalnyy A., Keane G. Current state and future outlook for develop-ment of the milk and beef sectors in Ukraine. Cattle husbandry in Eastern Europe and China / EAAP publications. Wageningen Academic Publishers. 2014. Vol. 135. P. 169–180. doi: 10.3920/978-90-8686-785-1_13.

Shams-White M.M., Chung M., Du M., Fu Z., Insogna K.L., Karlsen M.C., LeBoff M.S., Shapses S.A., Sackey J., Wallace T.C., Weaver C.M. Dietary protein and bone health: a systematic review and meta-analysis from the National Osteoporosis Foundation. The American Journal of Clinical Nutrition. 2017. Vol. 105 (6). P. 1528–1543. doi: 10.3945/ajcn.116.145110.

Lee J.S., Kim J.W. Prevalence of vitamin D deficiency in postmenopausal high- and low-energy fracture patient. Arch Osteo-poros. 2018. Vol. 13. P. 109.

Enattah N.S., Sahi T., Savilahti E., Terwilliger J.D., Peltonen L., Järvelä I. Identification of a variant associated with adult-typehypolactasia. Nat Genet. 2002. Vol. (2). P. 233–237.

Enattah N.S., Trudeau A., Pimenoff V., Maiuri L., Auricchio S., Greco L., Rossi M., Lentze M., Seo J.K., Rahgozar S., Khalil I., Alifrangis M. et al. Evidence of still-ongoing convergence evolution of the lactase persistence T(-13910) alleles in humans. Am. J. Hum. Genet. 2007. Vol. 81. P. 615–625.

Fedota O.M., Lysenko N.G., Ruban S.Yu., Kolisnyk O.I., Goraychuk I.V. Effects of Allelic Polymorphisms in GH and GHR Genes on Production and Reproduction Parameters of Cattle (Bostaurus L., 1758) of the Aberdeen-AngusBreed. Tsitologiya I Genetika. 2017. Vol. 5 (51). P. 38–49.

Fedota O., Roschenyuk L., Tyzhnenko T., Merenkova I., Vorontsov V. Pharmacogenetic effects of methotrexate in Ukrainian patientsdepending on the mthfr genotypes (clinical cases). Georgian Medical News. 2018. Vol. 6 (279). P. 111–117.

Coelho M., Luiselli D., Bertorelle G., Lopes A.I., Seixas S., Destro-Bisol G., Rocha J. Microsatellite variation and evolution of human lactase persistence. Hum. Genet. 2005. Vol. 117. P. 329–339.

Bersaglieri T., Sabeti P.C., Patterson N., Vanderploeg T., Schaffner S.F., Drake J.A., Rhodes M., Reich D.E., Hirschhorn J.N. Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet. 2004. Vol. 74 (6). P. 111–120.

Fedota O.M., Roshenyuk L.V., Gontar Y.V., Lysenko N.G., Babalian V.O., Tyzhnenko T.V., Sadovnychenko Y.A., Vorontsov V.M., Ryzhko P.P., Gerilovych A.P. Effects of inbreeding on linkage disequilibrium for SNPs of MTHFR, MTR, F5, LCT and VDR3 genes in Ukrainian population. European Conference of Human Genetics. Italy, Milan, 2018. P. 16–19.

Iacone R., Scanzano C., D’Isanto A., Vitalone A., Frangipane I., D’Angeli M., Santarpia L., ContaldoF. Prediction of Renal Acid Load in Adult Patients on Parenteral Nutrition. Pharmaceutics. 2018. Vol. 10 (2). P. 43. doi: 10.3390/pharmaceutics10020043.

Baranov V.S. Genetic passport – the basis of individual and predictive medicine: textbook. Saint-Petersburg, 2009. 528 p. [in Russian]

Weaver C.M., Proulx W.R., Heaney R. Choices for achieving adequate dietary calcium with a vegetarian diet. The American Journal of Clinical Nutrition. 1999. Vol. 70 (3). P. 543–548. doi: 10.1093/ajcn/70.3.543s.

Kettunen J., Silander K., Saarela O., Amin N., Müller M., Timpson N., Surakka I., Ripatti S., Laitinen J., Hartikainen A.L., Pouta A., Lahermo P., Anttila V., Männistö S., Jula A., Virtamo J., Salomaa V., Lehtimäki T., Raitakari O., Gieger C., Wichmann E.H., VanDuijn C.M., Smith G.D., McCarthy M.I., Järvelin M.R., Perola M., Peltonen L. European lactase persis-tence genotype shows evidence of association with increase in body mass index. Hum Mol Genet. 2010. Vol. 19 (6). P. 1129–1136. doi: 10.1093/hmg/ddp561.

Shams White M.M., Chung M., Du M., Fu Z., Insogna K.L., Karlsen M.C., LeBoff M.S., Shapses S.A., Sackey J., Wallace T.C., Weaver C.M. Dietary protein and bone health: a systematic review and meta-analysis from the National Osteoporosis Foundation. The American Journal of Clinical Nutrition. 2017. Vol. 105 (6). P. 1528–1543. doi: 10.3945/ajcn.116.145110.

Somekawa Y., Chiguchi M., Ishibashi T., Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol. 2001. Vol. 97 (1). P. 109–115.

Zhang X., Shu X.O., Li H., Yang G., Li Q., Gao Y.T. Prospective cohort study of soy food consumption and risk of bone frac-ture among postmenopausal women. Arch Intern Med. 2005. Vol. 165 (16). P. 1890–1895.

Bone H.G., Greenspan S.L., McKeever C., Bell N., Davidson M., Downs R.W., Emkey R., Meunier P.J., Miller S.S., Mulloy A.L., Recker R.R., Weiss S.R., Heyden N., Musliner T., Suryawanshi S., Yates A.J., Lombardi A. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate / Estrogen Study Group. J Clin Endocrinol Me-tab. 2000. Vol. 85 (2). P. 720.

Wei P., Liu M., Chen Y., Chen D.C. Systematic review of soy isoflavone supplements on osteoporosis in women. Asian Pac J Trop Med. 2012. Vol. 5 (3). P. 243–248. doi: 10.1016/S1995-7645(12)60033-9.